US Patent Issued to The Regents of the University of Michigan on Nov. 11 for "PRC1 inhibitors and methods of treatment therewith" (Michigan Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,813, issued on Nov. 11, was assigned to The Regents of the University of Michigan (Ann Arbor, Mich.).

"PRC1 inhibitors and methods of treatment therewith" was invented by Tomasz Cierpicki (Ann Arbor, Mich.), Jolanta Grembecka (Ann Arbor, Mich.), Weijiang Ying (Ann Arbor, Mich.), Yiwu Yao (Ann Arbor, Mich.), Felicia Gray (Ann Arbor, Mich.) and Qingjie Zhao (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are small molecule inhibitors of Polycomb Repressive Complex 1 (PRC1) activity, and methods of use thereof for the treatment of disease, including leukemia and other cancers, as well as other diseases dependent on the ...